Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD

NCT01391715 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped patients could not be recuited within study duration

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: rabeprazole
DRUG: standard dose rabeprazole

Sponsor

Inje University